HIV-1 protease inhibitors: development, status, and potential role in the treatment of AIDS.
Lang
M
M
Pharmaceuticals Division, CIBA-GEIGY Limited, Basel, Switzerland.
Roesel
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000201:enzymology*; D006801:Humans
D017320:HIV Protease Inhibitors